The George Washington Cancer Center
Washington D.C., District of Columbia 20052
1 studies enrolling now · 2 studies all time
What they study most
Metastatic Head and Neck Cancer, Recurrent Head and Neck Cancer, Solid Tumors, Unresectable Head and Neck Squamous Cell Carcinoma
Studies at this site
- A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1 — Recruiting now
- Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors — Running, not enrolling